Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.75B Activated in VL: True Average Daily Range Avg Daily Range: $1.52 | 3.47% Avg Daily Range (30 D): $0.84 | 3.51% Avg Daily Range (90 D): $0.76 | 3.33% Institutional Daily Volume Avg Daily Volume: .98M Avg Daily Volume (30 D): 1.96M Avg Daily Volume (90 D): 2.23M Trade Size Avg Trade Size (Sh.): 59 Avg Trade Size (Sh.) (30 D): 61 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 3,230 Avg Inst. Trade: $3.14M Avg Inst. Trade (30 D): $2.51M Avg Inst. Trade (90 D): $3.16M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.87M Avg Closing Trade (30 D): $4.66M Avg Closing Trade (90 D): $5.19M Avg Closing Volume: 140.14K     News Dec 6, 2025 @ 1:00 PM Beam Therapeutics Reports Updated Data from BEACON... Source: Beam Therapeutics Jun 28, 2025 @ 1:10 PM 10 Under-the-Radar Healthcare Stocks With Incredib... Source: Dan Victor Jun 17, 2025 @ 2:07 PM Editas Medicine Is Great. Here's Why You Shouldn't... Source: Dan Victor May 29, 2025 @ 8:01 PM Beam Therapeutics Announces U.S. FDA Orphan Drug D... Source: N/A May 6, 2025 @ 9:05 PM Why Beam Therapeutics Stock Tanked on Tuesday Source: Eric Volkman Financials   TTM Q3 2025 Q2 2025 Basic EPS $-4.42 $-1.1 $-1 Diluted EPS $-4.42 $-1.1 $-1 Revenue $ 55.7M $ 9.7M $ 8.47M Gross Profit $ $ $ Net Income / Loss $ -414.64M $ -112.73M $ -102.29M Operating Income / Loss $ -466.29M $ -126.81M $ -120.15M Cost of Revenue $ $ $ Net Cash Flow $ 37.86M $ -14.15M $ -245.75M PE Ratio